islet function and insulin resistance extent

	NC	NIT-NA	NIT-MA	NIT-LA;
HOMA-IR;	1.90 ± 0.50	3.73 ± 1.19^a	;4.64 ± 3.47^a	6.31 ± 2.62^a
HOMA-β	97.89 ± 22.90	56.21 ± 24.31^a	46.58 ± 38.08^a	38.55 ± 21.7^a
QUICKI	0.62 ± 0.04	0.53 ± 0.08^a	;0.53 ± 0.06^a	0.51 ± 0.17^a
Nampt (ng/mL)	8.56 ± 3.49	19.89 ± 4.01^a	29.07 ± 6.25^ab	37.64 ± 5.91abc
IL-1β (pg/mL)	76.96 ± 25.97	141.67 ± 35.11^a	195.45 ± 49.26^ab	276 ± 64.57abc

^aCompared with NC, P < 0.05; ^bCompared with NIT-NA, P < 0.05; ^cCompared with NIT-MA, P < 0.05
NC = Control group; NIT-NA = Normoalbuminuria in Non-Insulin Therapy group; NIT-MA = Microalbuminuria in Non-Insulin Therapy group; NIT-LA = Large Amount of albuminuria group in non-insulin therapy group; HOMA-IR = Homeostasis Model Assessment; HOMA-β = Homa beta cell function index; QUICKI = Quantitative Insulin Sensitivity Check Index; Nampt = Nicotinamide phosphoribosyltransferase ; IL-1β = Interleukin-1β

Table 3: Nampt, IL-1β, islet function and insulin resistance extent in NC and NIT group.